Antenatal dexamethasone for early preterm birth in low-resource countries

Autores
Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; Metin Gülmezoglu, A.; Bahl, Rajiv; Rao, Suman P.N.; de Costa, Ayesha; Gupta, Shuchita; Shahidullah, Mohammod; Chowdhury, Saleha B.; Ara, Gulshan; Akter, Shaheen; Akhter, Nasreen; Dey, Probhat R.; Abdus Sabur, M.; Azad, Mohammad T.; Choudhury, Shahana F.; Matin, M.A.; Goudar, Shivaprasad S.; Dhaded, Sangappa M.; Metgud, Mrityunjay C.; Pujar, Yeshita V.; Somannavar, Manjunath S.; Vernekar, Sunil S.; Herekar, Veena R.; Bidri, Shailaja R.; Mathapati, Sangamesh S.; Patil, Preeti G.; Patil, Mallanagouda M.; Gudadinni, Muttappa R.; Bijapure, Hidaytullah R.; Mallapur, Ashalata A.; Katageri, Geetanjali M.; Chikkamath, Sumangala B.; Yelamali, Bhuvaneshwari C.; Pol, Ramesh R.; Misra, Sujata S.; Das, Leena
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.
Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; Argentina
Fil: Vogel, Joshua P.. Organizacion Mundial de la Salud; Argentina
Fil: Piaggio, Gilda. Organizacion Mundial de la Salud; Argentina
Fil: Nguyen, My-Huong. Organizacion Mundial de la Salud; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; Argentina
Fil: Bahl, Rajiv. Organizacion Mundial de la Salud; Argentina
Fil: Rao, Suman P.N.. Organizacion Mundial de la Salud; Argentina
Fil: de Costa, Ayesha. Organizacion Mundial de la Salud; Argentina
Fil: Gupta, Shuchita. Organizacion Mundial de la Salud; Argentina
Fil: Shahidullah, Mohammod. No especifíca;
Fil: Chowdhury, Saleha B.. No especifíca;
Fil: Ara, Gulshan. No especifíca;
Fil: Akter, Shaheen. No especifíca;
Fil: Akhter, Nasreen. No especifíca;
Fil: Dey, Probhat R.. No especifíca;
Fil: Abdus Sabur, M.. No especifíca;
Fil: Azad, Mohammad T.. No especifíca;
Fil: Choudhury, Shahana F.. No especifíca;
Fil: Matin, M.A.. No especifíca;
Fil: Goudar, Shivaprasad S.. No especifíca;
Fil: Dhaded, Sangappa M.. No especifíca;
Fil: Metgud, Mrityunjay C.. No especifíca;
Fil: Pujar, Yeshita V.. No especifíca;
Fil: Somannavar, Manjunath S.. No especifíca;
Fil: Vernekar, Sunil S.. No especifíca;
Fil: Herekar, Veena R.. No especifíca;
Fil: Bidri, Shailaja R.. No especifíca;
Fil: Mathapati, Sangamesh S.. No especifíca;
Fil: Patil, Preeti G.. No especifíca;
Fil: Patil, Mallanagouda M.. No especifíca;
Fil: Gudadinni, Muttappa R.. No especifíca;
Fil: Bijapure, Hidaytullah R.. No especifíca;
Fil: Mallapur, Ashalata A.. No especifíca;
Fil: Katageri, Geetanjali M.. No especifíca;
Fil: Chikkamath, Sumangala B.. No especifíca;
Fil: Yelamali, Bhuvaneshwari C.. No especifíca;
Fil: Pol, Ramesh R.. No especifíca;
Fil: Misra, Sujata S.. No especifíca;
Fil: Das, Leena. No especifíca;
Materia
Dexamethasone
Early preterm birth
Low-resource countries
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/142666

id CONICETDig_ce834963f5828cf7190ef2d9dbdbf0cd
oai_identifier_str oai:ri.conicet.gov.ar:11336/142666
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Antenatal dexamethasone for early preterm birth in low-resource countriesOladapo, Olufemi T.Vogel, Joshua P.Piaggio, GildaNguyen, My-HuongAlthabe, FernandoMetin Gülmezoglu, A.Bahl, RajivRao, Suman P.N.de Costa, AyeshaGupta, ShuchitaShahidullah, MohammodChowdhury, Saleha B.Ara, GulshanAkter, ShaheenAkhter, NasreenDey, Probhat R.Abdus Sabur, M.Azad, Mohammad T.Choudhury, Shahana F.Matin, M.A.Goudar, Shivaprasad S.Dhaded, Sangappa M.Metgud, Mrityunjay C.Pujar, Yeshita V.Somannavar, Manjunath S.Vernekar, Sunil S.Herekar, Veena R.Bidri, Shailaja R.Mathapati, Sangamesh S.Patil, Preeti G.Patil, Mallanagouda M.Gudadinni, Muttappa R.Bijapure, Hidaytullah R.Mallapur, Ashalata A.Katageri, Geetanjali M.Chikkamath, Sumangala B.Yelamali, Bhuvaneshwari C.Pol, Ramesh R.Misra, Sujata S.Das, LeenaDexamethasoneEarly preterm birthLow-resource countrieshttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; ArgentinaFil: Vogel, Joshua P.. Organizacion Mundial de la Salud; ArgentinaFil: Piaggio, Gilda. Organizacion Mundial de la Salud; ArgentinaFil: Nguyen, My-Huong. Organizacion Mundial de la Salud; ArgentinaFil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; ArgentinaFil: Bahl, Rajiv. Organizacion Mundial de la Salud; ArgentinaFil: Rao, Suman P.N.. Organizacion Mundial de la Salud; ArgentinaFil: de Costa, Ayesha. Organizacion Mundial de la Salud; ArgentinaFil: Gupta, Shuchita. Organizacion Mundial de la Salud; ArgentinaFil: Shahidullah, Mohammod. No especifíca;Fil: Chowdhury, Saleha B.. No especifíca;Fil: Ara, Gulshan. No especifíca;Fil: Akter, Shaheen. No especifíca;Fil: Akhter, Nasreen. No especifíca;Fil: Dey, Probhat R.. No especifíca;Fil: Abdus Sabur, M.. No especifíca;Fil: Azad, Mohammad T.. No especifíca;Fil: Choudhury, Shahana F.. No especifíca;Fil: Matin, M.A.. No especifíca;Fil: Goudar, Shivaprasad S.. No especifíca;Fil: Dhaded, Sangappa M.. No especifíca;Fil: Metgud, Mrityunjay C.. No especifíca;Fil: Pujar, Yeshita V.. No especifíca;Fil: Somannavar, Manjunath S.. No especifíca;Fil: Vernekar, Sunil S.. No especifíca;Fil: Herekar, Veena R.. No especifíca;Fil: Bidri, Shailaja R.. No especifíca;Fil: Mathapati, Sangamesh S.. No especifíca;Fil: Patil, Preeti G.. No especifíca;Fil: Patil, Mallanagouda M.. No especifíca;Fil: Gudadinni, Muttappa R.. No especifíca;Fil: Bijapure, Hidaytullah R.. No especifíca;Fil: Mallapur, Ashalata A.. No especifíca;Fil: Katageri, Geetanjali M.. No especifíca;Fil: Chikkamath, Sumangala B.. No especifíca;Fil: Yelamali, Bhuvaneshwari C.. No especifíca;Fil: Pol, Ramesh R.. No especifíca;Fil: Misra, Sujata S.. No especifíca;Fil: Das, Leena. No especifíca;Massachusetts Medical Society2020-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/142666Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-25250028-4793CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2022398info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:02Zoai:ri.conicet.gov.ar:11336/142666instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:02.326CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Antenatal dexamethasone for early preterm birth in low-resource countries
title Antenatal dexamethasone for early preterm birth in low-resource countries
spellingShingle Antenatal dexamethasone for early preterm birth in low-resource countries
Oladapo, Olufemi T.
Dexamethasone
Early preterm birth
Low-resource countries
title_short Antenatal dexamethasone for early preterm birth in low-resource countries
title_full Antenatal dexamethasone for early preterm birth in low-resource countries
title_fullStr Antenatal dexamethasone for early preterm birth in low-resource countries
title_full_unstemmed Antenatal dexamethasone for early preterm birth in low-resource countries
title_sort Antenatal dexamethasone for early preterm birth in low-resource countries
dc.creator.none.fl_str_mv Oladapo, Olufemi T.
Vogel, Joshua P.
Piaggio, Gilda
Nguyen, My-Huong
Althabe, Fernando
Metin Gülmezoglu, A.
Bahl, Rajiv
Rao, Suman P.N.
de Costa, Ayesha
Gupta, Shuchita
Shahidullah, Mohammod
Chowdhury, Saleha B.
Ara, Gulshan
Akter, Shaheen
Akhter, Nasreen
Dey, Probhat R.
Abdus Sabur, M.
Azad, Mohammad T.
Choudhury, Shahana F.
Matin, M.A.
Goudar, Shivaprasad S.
Dhaded, Sangappa M.
Metgud, Mrityunjay C.
Pujar, Yeshita V.
Somannavar, Manjunath S.
Vernekar, Sunil S.
Herekar, Veena R.
Bidri, Shailaja R.
Mathapati, Sangamesh S.
Patil, Preeti G.
Patil, Mallanagouda M.
Gudadinni, Muttappa R.
Bijapure, Hidaytullah R.
Mallapur, Ashalata A.
Katageri, Geetanjali M.
Chikkamath, Sumangala B.
Yelamali, Bhuvaneshwari C.
Pol, Ramesh R.
Misra, Sujata S.
Das, Leena
author Oladapo, Olufemi T.
author_facet Oladapo, Olufemi T.
Vogel, Joshua P.
Piaggio, Gilda
Nguyen, My-Huong
Althabe, Fernando
Metin Gülmezoglu, A.
Bahl, Rajiv
Rao, Suman P.N.
de Costa, Ayesha
Gupta, Shuchita
Shahidullah, Mohammod
Chowdhury, Saleha B.
Ara, Gulshan
Akter, Shaheen
Akhter, Nasreen
Dey, Probhat R.
Abdus Sabur, M.
Azad, Mohammad T.
Choudhury, Shahana F.
Matin, M.A.
Goudar, Shivaprasad S.
Dhaded, Sangappa M.
Metgud, Mrityunjay C.
Pujar, Yeshita V.
Somannavar, Manjunath S.
Vernekar, Sunil S.
Herekar, Veena R.
Bidri, Shailaja R.
Mathapati, Sangamesh S.
Patil, Preeti G.
Patil, Mallanagouda M.
Gudadinni, Muttappa R.
Bijapure, Hidaytullah R.
Mallapur, Ashalata A.
Katageri, Geetanjali M.
Chikkamath, Sumangala B.
Yelamali, Bhuvaneshwari C.
Pol, Ramesh R.
Misra, Sujata S.
Das, Leena
author_role author
author2 Vogel, Joshua P.
Piaggio, Gilda
Nguyen, My-Huong
Althabe, Fernando
Metin Gülmezoglu, A.
Bahl, Rajiv
Rao, Suman P.N.
de Costa, Ayesha
Gupta, Shuchita
Shahidullah, Mohammod
Chowdhury, Saleha B.
Ara, Gulshan
Akter, Shaheen
Akhter, Nasreen
Dey, Probhat R.
Abdus Sabur, M.
Azad, Mohammad T.
Choudhury, Shahana F.
Matin, M.A.
Goudar, Shivaprasad S.
Dhaded, Sangappa M.
Metgud, Mrityunjay C.
Pujar, Yeshita V.
Somannavar, Manjunath S.
Vernekar, Sunil S.
Herekar, Veena R.
Bidri, Shailaja R.
Mathapati, Sangamesh S.
Patil, Preeti G.
Patil, Mallanagouda M.
Gudadinni, Muttappa R.
Bijapure, Hidaytullah R.
Mallapur, Ashalata A.
Katageri, Geetanjali M.
Chikkamath, Sumangala B.
Yelamali, Bhuvaneshwari C.
Pol, Ramesh R.
Misra, Sujata S.
Das, Leena
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Dexamethasone
Early preterm birth
Low-resource countries
topic Dexamethasone
Early preterm birth
Low-resource countries
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.
Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; Argentina
Fil: Vogel, Joshua P.. Organizacion Mundial de la Salud; Argentina
Fil: Piaggio, Gilda. Organizacion Mundial de la Salud; Argentina
Fil: Nguyen, My-Huong. Organizacion Mundial de la Salud; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; Argentina
Fil: Bahl, Rajiv. Organizacion Mundial de la Salud; Argentina
Fil: Rao, Suman P.N.. Organizacion Mundial de la Salud; Argentina
Fil: de Costa, Ayesha. Organizacion Mundial de la Salud; Argentina
Fil: Gupta, Shuchita. Organizacion Mundial de la Salud; Argentina
Fil: Shahidullah, Mohammod. No especifíca;
Fil: Chowdhury, Saleha B.. No especifíca;
Fil: Ara, Gulshan. No especifíca;
Fil: Akter, Shaheen. No especifíca;
Fil: Akhter, Nasreen. No especifíca;
Fil: Dey, Probhat R.. No especifíca;
Fil: Abdus Sabur, M.. No especifíca;
Fil: Azad, Mohammad T.. No especifíca;
Fil: Choudhury, Shahana F.. No especifíca;
Fil: Matin, M.A.. No especifíca;
Fil: Goudar, Shivaprasad S.. No especifíca;
Fil: Dhaded, Sangappa M.. No especifíca;
Fil: Metgud, Mrityunjay C.. No especifíca;
Fil: Pujar, Yeshita V.. No especifíca;
Fil: Somannavar, Manjunath S.. No especifíca;
Fil: Vernekar, Sunil S.. No especifíca;
Fil: Herekar, Veena R.. No especifíca;
Fil: Bidri, Shailaja R.. No especifíca;
Fil: Mathapati, Sangamesh S.. No especifíca;
Fil: Patil, Preeti G.. No especifíca;
Fil: Patil, Mallanagouda M.. No especifíca;
Fil: Gudadinni, Muttappa R.. No especifíca;
Fil: Bijapure, Hidaytullah R.. No especifíca;
Fil: Mallapur, Ashalata A.. No especifíca;
Fil: Katageri, Geetanjali M.. No especifíca;
Fil: Chikkamath, Sumangala B.. No especifíca;
Fil: Yelamali, Bhuvaneshwari C.. No especifíca;
Fil: Pol, Ramesh R.. No especifíca;
Fil: Misra, Sujata S.. No especifíca;
Fil: Das, Leena. No especifíca;
description BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.
publishDate 2020
dc.date.none.fl_str_mv 2020-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/142666
Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-2525
0028-4793
CONICET Digital
CONICET
url http://hdl.handle.net/11336/142666
identifier_str_mv Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-2525
0028-4793
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2022398
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Massachusetts Medical Society
publisher.none.fl_str_mv Massachusetts Medical Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269197016498176
score 13.13397